Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Endpoint Mobile Now; and professional services, such as training and certification services, and advanced services. It serves federal and state and local agencies. The company is headquartered in Petah Tikva, Israel.

Cellebrite DI Ltd.

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Cellebrite DI (CLBT – Research Report) and Aeva Te...

Analysts Conflicted on These Technology Names: Cellebrite DI (CLBT) and Aeva Technologies (AEVA)

In a report released today, Eric Martinuzzi from Lake Street maintained a Buy rating on Cellebrite DI, with a price target of $23.00. Martinuzzi co...

Lake Street Sticks to Its Buy Rating for Cellebrite DI (CLBT)

Cellebrite DI ( ($CLBT) ) has shared an announcement. On December 1, 2025, Cellebrite DI Ltd. completed its acquisition of Corellium, a leader in A...

Market Cap	$4.40B	P/E Ratio	52.28
52W High	$26.30	52W Low	$13.10
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	-68.2%	52W Position	43.3%
Overall Score	58	Value Score	20
Quality Score	65	Technical Score	90

EPS Current Est	$0.36	EPS Next Est	$0.44
EPS Growth Est	+22.2%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CLBT	$18.82	-1.26%	1.19M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CLBT	$18.82	-1.3%	1.19M
3
4
5
6

CLBT

CLBT

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Cellebrite DI Ltd. Data in Excel

Get Cellebrite DI Ltd. Data in Excel